As cell and gene-based therapies continue to reshape modern medicine, understanding the fundamentals is increasingly important. Particularly for those early in their careers. With new technologies, terminology, and development pathways emerging rapidly, it can be hard to know where to start.

Cell and Gene Therapy 101 was created to provide a clear, practical introduction to the field, in the lead-up to ELRIG’s Cell & Gene Therapy conference. This on-demand webinar is designed to help early career professionals build confidence in the core concepts that underpin these therapies and understand how they progress from research to patients.

What this webinar covers

In this session, you’ll learn:

• The foundational principles behind cell and gene therapies and how they differ from conventional medicines

• Where these approaches are already changing standards of care

• The stepwise journey from scientific idea to clinical-ready therapy

• Key development challenges, including:

  • Managing off-target effects

  • Achieving durable therapeutic responses

  • Scaling manufacture

  • Navigating evolving regulatory expectations

Watch the recording back now

*If the webinar does not appear, please ensure you have accepted the “Experience” cookies for this website. Alternatively, you can view it directly on YouTube here.

Webinar highlights: your questions answered

What are cell and gene therapies, and why do they matter?
Cell & gene therapies differ from traditional medicines by targeting the underlying causes of disease rather than managing symptoms. Real-world examples include treatments for spinal muscular atrophy (SMA), which are already transforming patient outcomes.

What types of technologies are involved?
The core approaches shaping the field today feature gene addition and editing, viral and non-viral delivery systems, and engineered cell therapies such as CAR-T.

What skills and career paths exist in this space?
There is a wide range of roles involved in advancing these therapies, from lab-based science and translational research to regulation, manufacturing, and technology development.